en · de · es · fr · pt
cjc-1295-notes.peptides1004.com › Faq › Background And Molecular Design — 2026 Update

Background And Molecular Design — 2026 Update

By Editorial Desk · published 2025-08-26 · last reviewed 2025-09-27 · Faq

The short version of Drug affinity complex fits in a sentence. The long version — which is the one that helps — is below.

Reviewed 2025-09-27. Anything still debated is marked as such rather than presented as settled.

Background and Molecular Design

CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.

Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.

Handling Storage And Analytical Methods

Purity is most often assessed by reversed-phase high-performance liquid chromatography, reported as a percentage of total peak area. Identity is confirmed by mass spectrometry, which yields a molecular ion consistent with the expected sequence. Amino acid analysis and peptide mapping provide additional characterization. Reported purity values are method-dependent, so figures from different laboratories are not always directly comparable without details of column, gradient, and detection wavelength.

Peptide degradation proceeds mainly through hydrolysis, oxidation of methionine, and deamidation of asparagine or glutamine residues. The maleimide group on the albumin-binding variant can also react with thiols or hydrolyze in aqueous media. Because these pathways accelerate with temperature and pH extremes, handling conditions strongly influence measured stability. Stability data in the public literature are limited and often generated under differing conditions, so general statements about shelf life should be read as approximate.

Research material is normally supplied as a freeze-dried powder in sealed vials. In that state the peptide is comparatively robust, but prolonged exposure to warmth, moisture, or light accelerates degradation. Storage at minus twenty degrees Celsius or lower, with desiccant and protection from light, is the commonly described practice. Vials should be allowed to reach room temperature before opening to limit condensation on the powder. Moisture uptake during handling is a recognized source of variability in later measurements.

Cjc-1295 at a glance

PropertyValueNotes
AppearanceWhite to off-white lyophilized powderVisual descriptor; not a measure of purity
Solubility classFreely soluble in waterAqueous dissolution may require gentle mixing
Typical storage (powder)−20 °C or below, desiccatedProtect from light and ambient moisture
Typical storage (solution)2–8 °C, short termFreeze aliquots where longer holding is needed
Purity assessmentReversed-phase HPLC, area percentValues depend on column, gradient, and detection wavelength

CJC-1295 Structure And Mechanism

The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.

Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.

Related pages on this site

CJC-1295 Background and Mechanism

CJC-1295 is a synthetic peptide designed to mimic growth hormone-releasing hormone (GHRH), the endogenous signal that prompts the pituitary gland to release growth hormone. The compound is a modified fragment of the natural hormone, spanning the first twenty-nine amino acids of GHRH with several substitutions that slow enzymatic breakdown. Two variants circulate in research settings: one carrying a drug affinity complex (DAC) and one without it. The DAC-free form is frequently labelled Mod GRF(1-29) in catalogs and discussion forums.

The peptide binds GHRH receptors on somatotroph cells within the anterior pituitary, triggering a signalling cascade that increases growth hormone secretion. Its improved resistance to dipeptidyl peptidase IV degradation distinguishes it from the parent hormone. In the DAC-bearing version, a maleimide group reacts with a cysteine residue on serum albumin, forming a covalent bond that keeps the peptide in circulation far longer. That albumin attachment is the central design feature separating the two research variants.

Further detail

=== Aquatic life === The environmental impact of CEC on aquatic life is broad. For example, endocrine-disrupting chemicals (EDCs) have the potential to imitate natural hormones, which can lead to reproductive failures and eventually population declines or increases in fish and amphibians. EDCs are found in a variety of common contaminants, including pesticides and industrial chemicals, and they can also lead to altered growth and reproduction in aquatic life (US EPA) (USGS.gov). Microplastics are another concern, as they can lead to physical blockages in the digestive tracts of aquatic organisms and act as paths for other toxins, leading to bioaccumulation and increase in concentration as they move up each level of the food chain. These impacts not only threaten biodiversity but also the stability of aquatic ecosystems upon which many species depend. Ongoing monitoring and regulatory efforts are crucial for assessing the full scope of CEC' impacts and for the development of effective strategies to mitigate their presence in aquatic ecosystems (NOAA.gov).

=== Singles === "Ace Is in the House" with Tone Loc (1994) "Cuban Pete" (1995) – AUS No. 88, UK No. 31 "Somebody to Love" (1996) – AUS No. 62 "Cold Dead Hand" (2013) (as Lonesome Earl and the Clutterbusters)

9 December – In a speech to European finance leaders in Brussels, Chancellor Rachel Reeves says that closer relations between the UK and the European Union will boost economic growth. The UK and German governments agree a new deal aimed at prosecuting those who smuggle migrants. Cammy Day confirms he has stepped down as leader of Edinburgh City Council after Police Scotland launched an investigation into allegations he bombarded Ukrainian refugees with questions, including those of a sexual nature. 10 December – A Scottish Government spokesman confirms that First Minister John Swinney has spoken by phone with US president-elect Donald Trump for the first time since his re-election, and described the 20 minute discussion as "positive". The Scottish Government backs plans to bar dual mandates – MSPs who also sit as MPs or members of the House of Lords – from sitting at Holyrood after the 2026 Scottish Parliament election. 10 December – The Stormont Assembly debates Northern Ireland's post-Brexit trade agreement, and votes to extend it for a further four years. Billionaire property developer and former Conservative donor Nick Candy is appointed as Reform UK's treasurer. 11 December – A Parliamentary committee is established to examine the Terminally Ill Adults (End of Life) Bill. 12 December – The House of Lords Conduct Committee recommends Conservative peer Baroness Meyer should be suspended for three weeks for calling a peer of Indian origin "Lord Poppadum" after an investigation found her comments amounted to harassment.

== Regulation == SHBG has both enhancing and inhibiting hormonal influences and thus can be viewed as a hepatokine. It decreases with high levels of insulin, growth hormone, insulin-like growth factor 1 (IGF-1), androgens, prolactin and transcortin. High estrogen and thyroxine levels cause it to increase. In an effort to explain obesity-related reductions in SHBG, recent evidence suggests sugar or monosaccharide-induced hepatic lipogenesis, hepatic lipids in general, and cytokines like TNF-alpha and interleukins reduce SHBG, whereas insulin does not. For example, anti-psoriatic drugs that inhibit TNF-alpha cause an increase in SHBG. The common downstream mechanism for all of these, including the effect of thyroid hormones, was downregulation of hepatocyte nuclear factor 4 (HNF4).

In 1974, GM offered driver and passenger airbags as optional equipment on large Cadillacs, Buicks, and Oldsmobiles. In 1976, the crash test dummy Hybrid III was introduced to assess the impacts of car collisions. It represented the 50th percentile male standing at approximately 5' 9" tall and weighing 78 kg (171 lbs). In 1979, NHTSA began crash-testing popular cars and publishing the results, to inform consumers and encourage manufacturers to improve the safety of their vehicles. Initially, the US NCAP (New Car Assessment Program) crash tests examined compliance with the occupant-protection provisions of FMVSS 208. Over the subsequent years, this NHTSA program was gradually expanded in scope.

Sources: en.wikipedia.org

Background from the literature

Tetraloop-receptor interactions combine base-pairing and stacking interactions between the loop nucleotides of a tetraloop motif and a receptor motif located within an RNA duplex, creating a tertiary contact that stabilizes the global tertiary fold of an RNA molecule. Tetraloops are also possible structures in DNA duplexes. Stem-loops can vary greatly in size and sequence, but tetraloops of four nucleotides are very common and they usually belong to one of three categories, based on sequence. These three families are the CUYG, UNCG, and GNRA (see figure on the right) tetraloops. In each of these tetraloop families, the second and third nucleotides form a turn in the RNA strand and a base-pair between the first and fourth nucleotides stabilizes the stemloop structure. It has been determined, in general, that the stability of the tetraloop depends on the composition of bases within the loop and on the composition of this "closing base pair". The GNRA family of tetraloops is the most commonly observed within Tetraloop-receptor interactions. Additionally, the UMAC tetraloops are known to be alternative versions of the GNRA loops, both sharing similar backbone structures; despite the similarities, they differ in the possible long-range interactions they are capable of.

The fissile properties of uranium-233 were established at the University of California, Berkeley during 1941 and early 1942 by Glenn T. Seaborg, John W. Gofman and Raymond W. Stoughton, who showed that the isotope undergoes fission with slow neutrons and was therefore a potential nuclear fuel. Their report was mailed to the Uranium Committee in Washington on 14 April 1942, but wartime secrecy kept the work from open publication until 1947, when an abridged version appeared in Physical Review. In 1946, the public first became informed of uranium-233 bred from thorium as "a third available source of nuclear energy and atom bombs" (in addition to uranium-235 and plutonium-239), following a United Nations report and a speech by Glenn T. Seaborg. The United States produced, over the course of the Cold War, approximately 2 metric tons of uranium-233, in varying levels of chemical and isotopic purity. These were produced at the Hanford Site and Savannah River Site in reactors that were designed for the production of plutonium-239.

== Further reading == Lebovitz, Harold E. (2004). Therapy For Diabetes Mellitus and Related Disorders (4th ed.). Alexandria, VA: American Diabetes Association. ISBN 978-1-58040-187-6. Adams, Michael Ian, Holland, Norman Norwood (2003). Core Concepts in Pharmacology. Englewood Cliffs, NJ: Prentice Hall. ISBN 978-0-13-089329-1.

== Use and storage == Soy sauce may be added directly to food and is commonly used as a dipping sauce or used as seasoning in cooking. It is often eaten with rice, noodles, sushi, or sashimi, or mixed with ground wasabi for dipping. Bottles of soy sauce for the purpose of seasoning dishes are common on restaurant tables in many countries. Soy sauce is indefinitely shelf-stable.

Sources: en.wikipedia.org

Frequently asked questions

How should the dry powder be stored?

Cool, dark, and dry conditions are standard, with storage at minus twenty degrees Celsius or below. Desiccant and sealed vials limit moisture uptake. Repeated warming and cooling of the container is generally avoided.

Does a solution need to be used immediately?

There is no single agreed limit, and laboratory practice varies widely. Refrigeration slows degradation, and freezing aliquots is often described for longer holding. Any visible cloudiness or precipitate indicates the solution should be discarded.

Which analytical methods confirm identity?

Mass spectrometry provides the most direct confirmation through molecular mass. Reversed-phase chromatography supports purity assessment, and peptide mapping or amino acid analysis can corroborate sequence. No single method establishes both purity and identity on its own.

How does CJC-1295 differ from modified GRF(1-29)?

The two share the same 29-amino-acid backbone. CJC-1295 carries an additional albumin-binding moiety that markedly extends its residence time in circulation, while the form without that moiety clears faster. Literature sometimes applies the name loosely to either variant.

Network